These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 20634300

  • 1. Addition of azathioprine to corticosteroids does not benefit patients with IgA nephropathy.
    Pozzi C, Andrulli S, Pani A, Scaini P, Del Vecchio L, Fogazzi G, Vogt B, De Cristofaro V, Allegri L, Cirami L, Procaccini AD, Locatelli F.
    J Am Soc Nephrol; 2010 Oct; 21(10):1783-90. PubMed ID: 20634300
    [Abstract] [Full Text] [Related]

  • 2. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Oct; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 3. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 4. Prednisolone and azathioprine in IgA nephropathy - a ten-year follow-up study.
    Goumenos DS, Davlouros P, El Nahas AM, Ahuja M, Shortland JR, Vlachojannis JG, Brown CB.
    Nephron Clin Pract; 2003 Jun 06; 93(2):C58-68. PubMed ID: 12616032
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec 06; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 6. Corticosteroid Treatment Influences TA-Proteinuria and Renal Survival in IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Visciano B, Pani A, De Silvestri A, De Simone I, Del Vecchio L, Terraneo V, Furiani S, Santagostino G, Corghi E, Pozzi C.
    PLoS One; 2016 Dec 06; 11(7):e0158584. PubMed ID: 27416024
    [Abstract] [Full Text] [Related]

  • 7. Combined treatment with steroids and azathioprine in IgA nephropathy: design of a prospective randomised multicentre trial.
    Locatelli F, Pozzi C, Del Vecchio L, Andrulli S, Pani A, Fogazzi G, Altieri P, Ponticelli C.
    J Nephrol; 1999 Dec 06; 12(5):308-11. PubMed ID: 10630693
    [Abstract] [Full Text] [Related]

  • 8. Comparison of combined leflunomide and low-dose corticosteroid therapy with full-dose corticosteroid monotherapy for progressive IgA nephropathy.
    Min L, Wang Q, Cao L, Zhou W, Yuan J, Zhang M, Che X, Mou S, Fang W, Gu L, Zhu M, Wang L, Yu Z, Qian J, Ni Z.
    Oncotarget; 2017 Jul 18; 8(29):48375-48384. PubMed ID: 28415636
    [Abstract] [Full Text] [Related]

  • 9. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy.
    Rauen T, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, Panzer U, Peters H, Benck U, Mertens PR, Kuhlmann U, Witzke O, Gross O, Vielhauer V, Mann JFE, Hilgers RD, Floege J.
    J Am Soc Nephrol; 2018 Jan 18; 29(1):317-325. PubMed ID: 29042456
    [Abstract] [Full Text] [Related]

  • 10. Corticosteroids could improve the renal outcome of IgA nephropathy with moderate proteinuria.
    Zhong Z, Tang Y, Tan J, Tan L, Pei G, Qin W.
    Int Urol Nephrol; 2021 Jan 18; 53(1):121-127. PubMed ID: 32944888
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of immunosuppressive therapy in IgA nephropathy presenting with isolated hematuria.
    Harmankaya O, Oztürk Y, Baştürk T, Obek A, Kiliçarslan I.
    Int Urol Nephrol; 2002 Jan 18; 33(1):167-71. PubMed ID: 12090325
    [Abstract] [Full Text] [Related]

  • 12. Corticosteroid effectiveness in IgA nephropathy: long-term results of a randomized, controlled trial.
    Pozzi C, Andrulli S, Del Vecchio L, Melis P, Fogazzi GB, Altieri P, Ponticelli C, Locatelli F.
    J Am Soc Nephrol; 2004 Jan 18; 15(1):157-63. PubMed ID: 14694168
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan 18; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 14. A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.
    Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C.
    Clin J Am Soc Nephrol; 2006 Sep 18; 1(5):925-32. PubMed ID: 17699309
    [Abstract] [Full Text] [Related]

  • 15. Combined Immunosuppressive Treatment May Improve Short-Term Renal Outcomes in Chinese Patients with Advanced IgA Nephropathy.
    Tan L, Tang Y, Peng W, Mathew BS, Qin W.
    Kidney Blood Press Res; 2018 Sep 18; 43(4):1333-1343. PubMed ID: 30099439
    [Abstract] [Full Text] [Related]

  • 16. Combined immunosuppression in high-risk patients with IgA nephropathy?
    Floege J, Eitner F.
    J Am Soc Nephrol; 2010 Oct 18; 21(10):1604-6. PubMed ID: 20829408
    [No Abstract] [Full Text] [Related]

  • 17. The prognostic effect of immunosuppressive therapy in IgA nephropathy with stage 3 or 4 chronic kidney disease.
    Yang X, Ma F, Bai M, Wang Y, Jia Q, Dong R, Liu C, Sun S.
    Ren Fail; 2021 Aug 10; 43(1):1180-1187. PubMed ID: 34376108
    [Abstract] [Full Text] [Related]

  • 18. Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.
    Tesar V, Troyanov S, Bellur S, Verhave JC, Cook HT, Feehally J, Roberts IS, Cattran D, Coppo R, VALIGA study of the ERA-EDTA Immunonephrology Working Group.
    J Am Soc Nephrol; 2015 Sep 10; 26(9):2248-58. PubMed ID: 25677392
    [Abstract] [Full Text] [Related]

  • 19. Comparison of steroid-pulse therapy and combined with mizoribine in IgA nephropathy: a randomized controlled trial.
    Masutani K, Tsuchimoto A, Yamada T, Hirakawa M, Mitsuiki K, Katafuchi R, Hirakata H, Kitazono T, Tsuruya K, West Japan Study Group for Therapy of IgA Nephropathy Investigators.
    Clin Exp Nephrol; 2016 Dec 10; 20(6):896-903. PubMed ID: 26758039
    [Abstract] [Full Text] [Related]

  • 20. Supportive Versus Immunosuppressive Therapy of Progressive IgA nephropathy (STOP) IgAN trial: rationale and study protocol.
    Eitner F, Ackermann D, Hilgers RD, Floege J.
    J Nephrol; 2008 Dec 10; 21(3):284-9. PubMed ID: 18587715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.